Current recommendations and emerging options for the treatment of allergic rhinitis

Amelia Licari, Giorgio Ciprandi, Alessia Marseglia, Riccardo Castagnoli, Salvatore Barberi, Silvia Caimmi, Gian Luigi Marseglia

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

Original languageEnglish
Pages (from-to)1337-1347
Number of pages11
JournalExpert Review of Clinical Immunology
Volume10
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Comorbidity
Asthma
Guidelines
Therapeutics
Population
Allergic Rhinitis
Global Health

Keywords

  • allergic rhinitis
  • drugs
  • efficacy
  • immunology
  • inflammation
  • safety
  • therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Current recommendations and emerging options for the treatment of allergic rhinitis. / Licari, Amelia; Ciprandi, Giorgio; Marseglia, Alessia; Castagnoli, Riccardo; Barberi, Salvatore; Caimmi, Silvia; Marseglia, Gian Luigi.

In: Expert Review of Clinical Immunology, Vol. 10, No. 10, 01.10.2014, p. 1337-1347.

Research output: Contribution to journalArticle

Licari, Amelia ; Ciprandi, Giorgio ; Marseglia, Alessia ; Castagnoli, Riccardo ; Barberi, Salvatore ; Caimmi, Silvia ; Marseglia, Gian Luigi. / Current recommendations and emerging options for the treatment of allergic rhinitis. In: Expert Review of Clinical Immunology. 2014 ; Vol. 10, No. 10. pp. 1337-1347.
@article{26cdf76278454f4eb362f9c5adbe3ff5,
title = "Current recommendations and emerging options for the treatment of allergic rhinitis",
abstract = "Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30{\%} of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.",
keywords = "allergic rhinitis, drugs, efficacy, immunology, inflammation, safety, therapy",
author = "Amelia Licari and Giorgio Ciprandi and Alessia Marseglia and Riccardo Castagnoli and Salvatore Barberi and Silvia Caimmi and Marseglia, {Gian Luigi}",
year = "2014",
month = "10",
day = "1",
doi = "10.1586/1744666X.2014.955476",
language = "English",
volume = "10",
pages = "1337--1347",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - Current recommendations and emerging options for the treatment of allergic rhinitis

AU - Licari, Amelia

AU - Ciprandi, Giorgio

AU - Marseglia, Alessia

AU - Castagnoli, Riccardo

AU - Barberi, Salvatore

AU - Caimmi, Silvia

AU - Marseglia, Gian Luigi

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

AB - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

KW - allergic rhinitis

KW - drugs

KW - efficacy

KW - immunology

KW - inflammation

KW - safety

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=84907278919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907278919&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2014.955476

DO - 10.1586/1744666X.2014.955476

M3 - Article

C2 - 25225773

AN - SCOPUS:84907278919

VL - 10

SP - 1337

EP - 1347

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 10

ER -